Intrauterine contraceptive devices (IUCDs) are long-acting, reversible contraception devices used by millions of women throughout the world. Despite its efficacy, consumers stop using it for a variety of reasons.
At Rivers State University Teaching Hospital (RSUTH), Port Harcourt, the goal was to assess the prevalence rate, side effects, discontinuation rate, and reasons for cessation of Cu T380A.
Methods: A retrospective analysis of 874 individuals who visited the RSUTH's family planning clinic between January 1, 2015 and December 31, 2019. Their medical records were retrieved and evaluated at the clinic. The statistical software for social sciences (SPSS) IBM version 25.0 was used to extract, code, and analyse data (Armonk, NY).
Results: During the research period, 221 of the 874 contraceptive acceptors accepted and utilised Cu T380A, yielding a prevalence rate of 25.3 percent. The average age was 37.87 years plus 5.01 years. The modal age group, which accounted for 81 percent of the total, was 35-39 years (36.7 percent ). The participants ranged in age from 23 to 51 years old, with the majority (63.8%) being multiparous. The majority of the clients (217, or 98.2%) had formal education and were married (219). (99.1 percent ). Menorrhagia was the most prevalent cause for discontinuance, accounting for 14 (21.6%); desire for conception, 13 (20%); abnormal vaginal bleeding, and menopause, each accounting for 8 percent (12.3 percent ). Missing string, which accounted for 6 (9.2%), vaginal discharge, sexual issues, lower abdominal, and waist aches, which each accounted for 5 (7.7%). There was one pregnancy that was unplanned.
Copper T380A is both safe and effective. The most prevalent adverse effects were menorrhagia and abnormal vaginal bleeding. The grounds for its cessation were pregnancy desire and adverse effects.
Please click here: https://journaljammr.com/index.php/JAMMR/article/view/30678
No comments:
Post a Comment